Docmode Health Technologies (NSE:DHTL) Altman Z2-Score: -0.01 (As of Jun. 29, 2026)


NSE:DHTL Docmode Health Technologies Ltd NSE:DHTL
14 GF Score
Price ₹40.50
View Full Analysis

What is Docmode Health Technologies Altman Z2-Score?

Docmode Health Technologies NSE:DHTL 14 Altman Z2-Score is -0.01 as of Jun. 29, 2026. GuruFocus rates NSE:DHTL with a GF Score™ of 14/100. Among 675 Healthcare Providers & Services companies, Docmode Health Technologies ranks worse than 70.67% on this metric.

Altman Z2-Score, also known as Z"-Score, is used to predict the likelihood that a non-manufacturing company (excluding property/financial company) will face bankruptcy within a two-year period.

Warning Sign:

Docmode Health Technologies has a Altman Z2-Score of -0.01, indicating it is in Distress Zones. This implies bankrupcy possibility in the next two years.

The zones of discrimination were as such:

When Altman Z2-Score <= 1.1, it is in Distress Zones.
When Altman Z2-Score >= 2.6, it is in Safe Zones.
When Altman Z2-Score is between 1.1 and 2.6, it is in Grey Zones.

The historical rank and industry rank for Docmode Health Technologies's Altman Z2-Score or its related term are showing as below:


Docmode Health Technologies  (NSE:DHTL) Altman Z2-Score Explanation

The original Z-Score model was based on publicly traded manufacturing companies while the Z2-Score, also known as Z"-score can be used for any type of company excluding property/financial companies. Both Z-Score and Z2-Score describes the financial health of a company, and its likelihood of financial distress.

X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.

X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.

X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.

X4_2, Net Worth (Total Stockholders Equity - Preferred Stock)/Total Liabilities (NW/TL): it compares a company’s stock net worth with its total liabilities and can be used to assess the extent of its reliance on debt.

Read more about Altman Z2-Score, the original research on Z-Score and the additional research on Z2-Score.


Be Aware

Altman Z2-Score does not apply to financial companies.


Docmode Health Technologies Altman Z2-Score Related Terms


Docmode Health Technologies Altman Z2-Score Historical Data

* Premium members only.

The historical data trend for Docmode Health Technologies's Altman Z2-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Docmode Health Technologies Altman Z2-Score Chart

Docmode Health Technologies Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25
Altman Z2-Score
2.44 4.01 3.89 2.73 -0.01

Docmode Health Technologies Semi-Annual Data
Mar21 Mar22 Mar23 Sep23 Mar24 Sep24 Mar25
Altman Z2-Score Get a 7-Day Free Trial 3.89 0.00 2.73 0.00 -0.01

NSE:DHTL vs VEEV, BTSG, TEM: Altman Z2-Score Comparison

For the Health Information Services subindustry, Docmode Health Technologies's Altman Z2-Score, along with its competitors' market caps and Altman Z2-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Docmode Health Technologies Altman Z2-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Docmode Health Technologies's Altman Z2-Score distribution charts can be found below:

* The bar in red indicates where Docmode Health Technologies's Altman Z2-Score falls into.


NSE:DHTL
14GF Score
Docmode Health Technologies Ltd NSE:DHTL
Altman Z2-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Docmode Health Technologies Altman Z2-Score Calculation

Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

Z2-Score, also known as Z"-Score is the Z-Score for non-manufacturing companies excluding property/financial companies.

Docmode Health Technologies's Altman Z2-Score for today is calculated with this formula:

Z=6.56*X1+3.26*X2+6.72*X3+1.05*X4_2
=6.56*-0.1084+3.26*0.1324+6.72*-0.0024+1.05*0.2696
=-0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z2-Score when X4_2 value is 0.

Trailing Twelve Months (TTM) ended in Mar. 2025:
Total Assets was ₹393.1 Mil.
Total Current Assets was ₹248.8 Mil.
Total Current Liabilities was ₹291.4 Mil.
Retained Earnings was ₹52.1 Mil.
Pre-Tax Income was ₹-19.7 Mil.
Interest Expense was ₹-18.7 Mil.
Total Liabilities was ₹309.6 Mil.

* Note that for stock reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data.

X1=Working Capital/Total Assets
=(Total Current Assets - Total Current Liabilities)/Total Assets
=(248.807 - 291.414)/393.114
=-0.1084

X2=Retained Earnings/Total Assets
=52.053/393.114
=0.1324

X3=Earnings Before Interest and Taxes/Total Assets
=(Pre-Tax Income - Interest Expense)/Total Assets
=(-19.652 - -18.701)/393.114
=-0.0024

X4_2=Net Worth/Total Liabilities
=(Total Stockholders Equity - Preferred Stock)/Total Liabilities
=(83.481 - 0)/309.63
=0.2696

The zones of discrimination were as such:

Distress Zones - 1.1 < Grey Zones < 2.6 - Safe Zones

Docmode Health Technologies has a Altman Z2-Score of -0.01 indicating it is in Distress Zones.

Frequently Asked Questions Learn more about Altman Z2-Score →
What does a Altman Z2-Score of -0.01 mean?
Docmode Health Technologies (NSE:DHTL) has a Altman Z2-Score of -0.01 as of Jun. 29, 2026. Z2-Score is the Z-Score for non-manufacturing companies excluding property/financial companies, which measures a company's bankruptcy risk. View historical data on Docmode Health Technologies and its competitors. According to the industry distribution chart, Docmode Health Technologies ranks #477 out of 675 companies in the Healthcare Providers & Services industry, placing it in the top 70.7%.
Is Docmode Health Technologies' Altman Z2-Score too high?
Docmode Health Technologies' current Altman Z2-Score is -0.01. Based on the distribution chart, Docmode Health Technologies ranks #477 out of 675 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Docmode Health Technologies has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Docmode Health Technologies' Altman Z2-Score compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Docmode Health Technologies ranks #477 out of 675 companies for Altman Z2-Score. This places Docmode Health Technologies in the lower half of its industry. The industry median Altman Z2-Score is 2.18. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z2-Score for a Healthcare Providers & Services company?
The median Altman Z2-Score among Healthcare Providers & Services companies is 2.18, based on 675 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z2-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z2-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z2-Score mean?
A high Altman Z2-Score can signal that a stock is expensive relative to its fundamentals. Z2-Score is the Z-Score for non-manufacturing companies excluding property/financial companies, which measures a company's bankruptcy risk. View historical data on Docmode Health Technologies and its competitors. For the Healthcare Providers & Services industry, the median Altman Z2-Score is 2.18 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Docmode Health Technologies's current Altman Z2-Score is -0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Docmode Health Technologies stock overvalued right now?
Docmode Health Technologies (NSE:DHTL) has a current Altman Z2-Score of -0.01. The current Altman Z2-Score is -0.01. Docmode Health Technologies' overall GF Score™ is 14/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z2-Score calculated?
Altman Z2-Score is calculated from a company's financial statements. For Docmode Health Technologies (NSE:DHTL), the current Altman Z2-Score is -0.01 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Docmode Health Technologies Business Description

Address Chincholi Bunder Road, 201, Kalpataru Plaza, Rambaug Off, Nadiyawala Colony 2, Malad, Mumbai, MH, IND, 400064
Docmode Health Technologies Ltd is engaged in the business of providing comprehensive & interactive learning programs for healthcare professionals through e-Learning measures and providing online CME (continuous medical education) Certification Courses and designing & conducting surveys, quizzes, questionnaires, etc. for collecting data insights related to the healthcare industry Its business segment is engaged in providing vocational training, DocMode is a platform that provides authoritative, comprehensive, and interactive learning programs for Health Professionals - Doctors, Nurses, Allied and Medical Students - across the world. The company has a new segments namely publishing of Medical books, trading of medical books and journals, conducting customised and inhouse events.
14GF Score

Get the complete analysis for NSE:DHTL

Altman Z2-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹40.50
Price